JPRN-UMIN000007922已完成未知
A multi-center registry evaluating the safety of carotid artery stenting in symptomatic and asymptomatic carotid artery stenosis patients in Japan - CASSIS Registry
A study group for therapy of carotid artery stenosis0 个研究点目标入组 400 人开始时间: 2012年5月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •4) Patients who have undergone CAS, CEA, PCI, EVT or vascular bypass within the past 30 days. 5) Patients currently enrolled or planning to enroll in clinical trial(s) that could affect the outcome of this study. 6) Patients for whom a follow up examination 30 days post-CAS would be difficult.
研究者
相似试验
进行中（未招募）
1 期
A multi-center study evaluating the safety of a replacement intravitreal fluocinolone acetonide (FA) (0.59 mg) implant in patients with non-infectious posterior uveitis who were previously treated with an intravitreal FA implantEUCTR2005-001589-15-GBBausch & Lomb Incorporated60
暂停
1 期
A multi-centre study of the safety, tolerability and effects of intravenously administered Cyclic Pyranopterin Monophosphate (cPMP) in patients with molybdenum cofactor deficiency type A.ACTRN12609000849291PMP(Vic) Pty Ltd10
未知
3 期
A multicenter, investigative study of the safety and efficacy of extended administration of aripiprazole in combination with mood stabilizer for the treatment of patients with bipolar disorder experiencing a manic or mixed episodeAcute manic and mixed episodes associated with Bipolar I DisorderJPRN-jRCT2080220515Otsuka Pharmaceutical Co., Ltd.
进行中（未招募）
4 期
Cephalexin Extended Release and Clavulanate Potassium Tablets in Patients with Upper Respiratory Tract Infection and Uncomplicated Skin & Soft Tissue Infection.CTRI/2022/07/044190Sun Pharma Laboratories Ltd
已完成
2 期
A Multi-Centre Clinical Study to Evaluate the Safety and Effectiveness of the ESS505® Device to Prevent Pregnancy in Women Who Are Seeking Permanent ContraceptioWomen ages range 21 to 44 years desiring permanent contraceptionbirth controlcontraceptionNL-OMON39616Bayer40